SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about acquisition

29 Jul 2020 Evaluate

Sun Pharmaceutical Industries has informed that that one of the wholly owned subsidiaries of its subsidiary company, Taro Pharmaceutical Industries has agreed to acquire by way of purchase of all outstanding shares of Aquinox Pharmaceuticals (Canada) Inc., a corporation organized and existing under the laws of the Province of British Columbia that carries on the business of research and development of pharmaceutical products for purposes of their commercialization. The disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, are attached as per ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma. Inds. Share Price

1874.80 8.85 (0.47%)
02-Jul-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.80
Dr. Reddys Labs. 1345.00
Cipla 1458.25
Zydus Lifesciences 1106.90
Lupin 2392.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: